{
    "2019-03-20": [
        [
            {
                "time": "2019-03-20",
                "original_text": "After Hours Most Active for Mar 20, 2019: NLY, XOG, GE, MCHI, ELAN, T, QQQ, MU, NWL, AMD, PFE, DIS",
                "features": {
                    "keywords": [
                        "Most Active",
                        "NLY",
                        "XOG",
                        "GE",
                        "MCHI",
                        "ELAN",
                        "T",
                        "QQQ",
                        "MU",
                        "NWL",
                        "AMD",
                        "PFE",
                        "DIS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Invest in Americaâ€™s Rising Healthcare Costs With These Stocks",
                "features": {
                    "keywords": [
                        "Invest",
                        "America",
                        "Healthcare Costs",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer buys stake in French gene therapy firm Vivet",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "buys",
                        "stake",
                        "French",
                        "gene therapy",
                        "Vivet"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Glaxo Presents Encouraging Data on Endometrial Cancer Drug",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Encouraging Data",
                        "Endometrial Cancer",
                        "Drug"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan",
                "features": {
                    "keywords": [
                        "Conatus",
                        "CNAT",
                        "Developing",
                        "NASH",
                        "Emricasan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Merck KGaA",
                        "End",
                        "Bavencio",
                        "Talzenna",
                        "Ovarian Cancer",
                        "Study"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer Acquires Gene Therapy Portfolio in Deal that Could Total $636 Million",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Acquires",
                        "Gene Therapy",
                        "Portfolio",
                        "$636 Million"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer Adds to Big Pharma's Gene-Therapy Deal Streak",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Adds",
                        "Big Pharma",
                        "Gene-Therapy",
                        "Deal Streak"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",
                "features": {
                    "keywords": [
                        "Daily Biotech Pulse",
                        "FDA",
                        "Sage",
                        "Postpartum Depression",
                        "Drug",
                        "Pfizer",
                        "Invests",
                        "Gene Therapy",
                        "Company"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "acquires",
                        "option",
                        "buy",
                        "Vivet Therapeutics",
                        "$635.8 million"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Secures",
                        "Exclusive Option",
                        "Acquire",
                        "Gene Therapy",
                        "Vivet Therapeutics"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "5 High-Quality, High-Yielding Stocks",
                "features": {
                    "keywords": [
                        "High-Quality",
                        "High-Yielding",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Stocks - FedEx, Google Fall in Pre-market; General Mills Jumps",
                "features": {
                    "keywords": [
                        "Stocks",
                        "FedEx",
                        "Google",
                        "Fall",
                        "Pre-market",
                        "General Mills",
                        "Jumps"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "transportation",
                        "technology",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Pfizer (PFE) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "PFE",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}